C
CADL
Candel Therapeutics, Inc.
4.830
+0.030+0.63%After Hours: 4.840 +0.010 +0.21%19:35 04/10 EDT
OPEN/PREV CLOSE4.820/4.800
TODAY RANGE4.760-4.860
VOL591.62K
MARKET CAP353.78M
52 WEEK RANGE4.250-7.25
AVG VOL (3M)1.16M
% TURNOVER0.81%
TURNOVER--
P/E (TTM)-6.6990
% RANGE2.08%
EPS(TTM)-0.7210
P/E(FORWARD)-3.7734
P/B5.11
BVPS0.9458
DIVIDEND--
P/S1,436.36
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP297.89M
SHARES OUTSTANDING73.25M
NEXT EARNINGS05/11-05/15
FREE FLOAT61.68M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·03/18 15:13
Candel Therapeutics Is Maintained at Buy by Citigroup
Dow Jones·03/18 15:13
Candel Therapeutics Price Target Raised to $26.00/Share From $22.00 by Citigroup
Benzinga·03/18 15:03
Citigroup Maintains Buy on Candel Therapeutics, Raises Price Target to $26
TipRanks·03/18 10:22
Candel Therapeutics price target raised to $26 from $22 at Citi
Reuters·03/18 07:36
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
Seeking Alpha·03/17 18:01
Candel gains on additional mid-stage trial data for lead asset
TipRanks·03/17 12:22
Candel Therapeutics’ aglatimagene shows extended long-term survival in NSCLC
Dow Jones·03/13 20:18
Candel Therapeutics Is Maintained at Buy by Citigroup
Same Industry
Name/Symbol
Change%
Price